RVPH - Reviva Pharmaceuticals Holdings Inc. Operating income before deduction of amortization
Reviva Pharmaceuticals (RVPH) is developing a scalable model characterized by low production costs and high margins. The implementation of software robots for data analysis is accelerating the drug pipeline. Operating cash flow before interest and taxes clearly captures these processes, where 0.00 serves as the current parameter value. High authority within the field of psychiatry confirms its status as an innovator creating safe therapies to return patients to social life.
Summary analytical data breakdowns for Reviva Pharmaceuticals Holdings, Inc. (RVPH)
- stock price and consensus target price:
- market capitalization statistics:
- balance sheet equity data:
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Reviva Pharmaceuticals|RVPH - Long-Term Debt to Equity|Current Liabilities to Equity Reviva Pharmaceuticals Holdings Inc.|RVPH - Company Aggregate Debts|Debt to Net Assets Ratio Reviva Pharmaceuticals|RVPH - Company Long-Term Debts|Company Short-Term Debts Reviva Pharmaceuticals|Intermediate Coverage Ratio revivapharma.com
- net income and valuation multiples indicators:
RVPH - Company Net Income|Future Profit Reviva Pharmaceuticals|RVPH - P/E Multiple|Forward P/E Multiple revivapharma.com|RVPH - PEG Multiple|Enterprise Value to EBITDA Ratio Reviva Pharmaceuticals|RVPH - Operating profit EBITDA|Net earnings per one share for the last twelve months Reviva Pharmaceuticals|RVPH - Net earnings per share for the last 12 months|Quarterly EPS earnings growth revivapharma.com|RVPH - Net earnings per share growth this year|Projected earnings per share increase next year Reviva Pharmaceuticals
Summary company analytics:Reviva Pharmaceuticals, Inc.
Steady progress through regulatory milestones for brexpiprazole establishes the foundation for future capitalization via a commercial launch in the US. This metric filters out paper revaluations by capturing actual daily cash inflows from core operations, allowing for a real-time assessment of business liquidity—excluding GAAP distortions—through the magnitude of Reviva Pharmaceuticals (RVPH) operating profit.
Who Reviva Pharmaceuticals competes with
Biogen Idec - Profit before payment of interest, taxes and amortization|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Operating profit EBITDA Viking Therapeutics Corp|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY (Harmony Biosciences Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|TRVI: Operating profit EBITDA|praxismedicines.com (PRAX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|CBLL: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Operating profit before deduction of amortization alector.com ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|Neurogene - Operating profit EBITDA|AC Immune S.A. (ACIU) - Operating profit before deduction of amortization|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Corp (NMRA)|Operating profit before deduction of amortization SCLX|Operating profit EBITDA tevogen.com|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Company profit before taxes, interest and amortization CGTX|Operating profit EBITDA IKT (Inhibikase)|Operating income before deduction of amortization Cassava Pharma (SAVA)|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|VTGN: Operating profit EBITDA|Ovid Therapeutics (OVID) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Acumen Pharma|Profit before payment of interest, taxes and amortization CRVO|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|Operating income before deduction of amortization clene.com|Profit before payment of interest, taxes and amortization PepGen PEPG|Income before deduction of interest, taxes and amortization JUNS|RLMD: Operating profit before deduction of amortization|ANVS: Profit before payment of interest, taxes and amortization|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization AIFF (fireflyneuro.com)|KLTO (ANEW Medical) - Operating profit EBITDA|NRSN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NeurAxis Inc - Operating profit before amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|NEUP: Operating profit before deduction of amortization|NERV - Operating profit EBITDA|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Addex - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Profit before interest, taxes and amortization Cyclerion CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA CRGT (Cortigent)|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|BCLI: Operating profit before deduction of amortization|CARA: Profit before payment of interest, taxes and amortization|CHRO: Operating profit EBITDA|ELYM - Operating income before deduction of amortization|Operating profit before deduction of amortization ITCI|Profit before payment of interest, taxes and amortization LBPH|Operating profit EBITDA MRNS|Operating profit EBITDA nkgenbiotech.com (NKGN)|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization TRVN|VIGL: Operating profit EBITDA|anewmeds.com - Income before deduction of interest, taxes and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
